A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma Meeting Abstract
| Authors: | Shoushtari, A. N.; Kudchadkar, R. R.; Panageas, K.; Murthy, R. K.; Jung, M.; Shah, R.; O'Donnell, B.; Khawaja, T. T.; Shames, Y.; Prempeh-Keteku, N. A.; Ambrosini, G.; Chan, H. X.; Chapman, P. B.; Schwartz, G. K.; Carvajal, R. D.; Patel, S. P. |
| Abstract Title: | A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 486s |
| Language: | English |
| ACCESSION: | WOS:000404711507133 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9511 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9511 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
